Does Lyme Disease Show Up on MRI? Brain Imaging and Cognitive Symptoms
MRI scans can be normal in Lyme disease.
Brain lesions may appear—but are not specific.
Advanced imaging may detect what MRI cannot.
Lyme disease does not always show up on MRI. Some patients develop white matter lesions or other changes, but many have normal scans despite significant neurologic symptoms.
In most cases, Lyme disease does not show up clearly on MRI.
In short: MRI may show abnormalities in Lyme disease—but a normal MRI does not rule it out.
Patients with Lyme disease frequently report cognitive symptoms such as memory problems, slowed processing, and difficulty concentrating. Yet conventional imaging studies are often unrevealing.
Emerging techniques such as magnetic resonance spectroscopy (MRS) may offer a deeper view into brain metabolism and function.
This disconnect between symptoms and testing reflects the broader diagnostic challenge discussed in Why Lyme Disease Tests the Limits of Medicine, where clinical illness does not always align with available tools.
What Brain MRI Shows in Lyme Disease
Brain MRI findings in Lyme disease are often nonspecific. Some patients demonstrate white matter changes similar to those seen in multiple sclerosis, while others have completely normal scans.
White matter lesions seen in Lyme disease can resemble those found in multiple sclerosis, which may complicate diagnosis without clinical context.
Reported abnormalities include lesions in periventricular or subcortical regions associated with cognitive function.
However, normal MRI findings do not exclude neurologic Lyme disease.
This pattern is commonly seen in persistent Lyme disease, where patients experience significant symptoms despite limited objective findings.
Why MRI Is Often Normal in Lyme Disease
MRI scans detect structural changes in the brain. However, many Lyme-related symptoms are caused by functional changes—such as inflammation, immune activation, or altered nerve signaling—that do not appear on standard imaging.
These functional changes may affect cognition, memory, and processing speed without producing visible abnormalities on MRI or CT scans.
Magnetic Resonance Spectroscopy (MRS): A Metabolic Window
Magnetic resonance spectroscopy (MRS) provides a noninvasive method to evaluate biochemical processes within the brain.
MRS allows measurement of neurotransmitters and metabolites, offering insight into cellular function rather than structure alone.
Advances in imaging technology—including higher field strength MRI systems such as 3 Tesla—have significantly improved the sensitivity of these techniques.
These improvements may allow clinicians to better detect subtle metabolic abnormalities associated with cognitive dysfunction.
Neurotransmitter Changes and Cognitive Impairment
Studies have shown that neurotransmitter levels may correlate with behavioral outcomes such as memory and reaction time.
In patients with mild cognitive impairment, researchers have identified characteristic metabolic changes, including:
- Decreased gamma-aminobutyric acid (GABA)
- Decreased glutamate (Glu)
- Decreased N-acetylaspartate (NAA)
- Increased myo-inositol (mI)
These findings suggest that altered brain metabolism may contribute to cognitive symptoms.
While not specific to Lyme disease, these patterns raise important questions about whether similar changes occur in patients with Lyme-related cognitive dysfunction.
Why This Matters in Lyme Disease
Up to 90% of patients with post-treatment Lyme disease syndrome (PTLDS) report cognitive symptoms such as brain fog, memory issues, and slowed processing. Advanced imaging (PET, fMRI, DTI) in these patients shows evidence of inflammation, glial activation, and changes in white matter structure【source: Fallon et al., J Neuropsychiatry Clin Neurosci, 2008】.
These findings suggest that structural imaging alone may underestimate neurologic involvement in Lyme disease.
Functional and metabolic imaging techniques may provide additional insight into these symptoms.
Clinical Perspective
Brain imaging in Lyme disease remains an evolving field.
While MRI findings are often nonspecific or normal, newer techniques such as MRS may offer valuable insights into brain metabolism and cognitive dysfunction.
Imaging results should be interpreted alongside clinical symptoms, exposure history, and laboratory findings.
When MRI findings are normal but symptoms persist, further evaluation may include clinical reassessment, consideration of co-infections, and targeted treatment approaches.
Future research may clarify whether advanced imaging can improve diagnosis and monitoring of neurologic Lyme disease.
Frequently Asked Questions
Does Lyme disease show up on MRI?
Sometimes. MRI may show white matter lesions or other changes, but many patients with neurologic Lyme disease have normal scans.
Can Lyme disease cause brain lesions?
Yes. Some patients develop white matter lesions, but these are not specific and may resemble other conditions such as multiple sclerosis.
Why is my MRI normal if I have cognitive symptoms?
MRI evaluates brain structure, not function. Functional and metabolic changes may not appear on standard imaging.
Is MRI useful for diagnosing Lyme disease?
MRI can support evaluation but cannot confirm or rule out Lyme disease on its own.
Related Articles
- Oppositional behavior in children with Lyme disease
- Brain response to sensory input
- Brain changes in acute Lyme neuroborreliosis
References
- Oeltzschner G, et al. Neurometabolites and associations with cognitive deficits in mild cognitive impairment. Neurobiol Aging. 2019.
- Tognarelli JM. Magnetic Resonance Spectroscopy: Principles and Techniques. J Clin Exp Hepatol. 2015.
- van der Graaf M. In vivo magnetic resonance spectroscopy. Eur Biophys J. 2010.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
